Orphazyme A/S (ORPH) received a Notice of Allowance for its US patent application 16/879,198 titled "ARIMOCLOMOL FOR TREATING GLUCOCEREBROSIDASE ASSOCIATED DISORDERS" - PatentGrants

October 13, 2021 1:11 PM EDT
Get Alerts ORPH Hot Sheet
Price: $4.25 +1.19%

Overall Analyst Rating:
    NEUTRAL (Down Down)

Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Orphazyme A/S (NASDAQ: ORPH) has received a Notice of Allowance for its US patent application 16/879,198 titled "ARIMOCLOMOL FOR TREATING GLUCOCEREBROSIDASE ASSOCIATED DISORDERS" - PatentGrants



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, Momentum Movers, Trader Talk